Loading
Latest filing published 23 Dec 2025 for IN8BIO, INC., €8,542.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Kate Rochlin on record concern In8bio, Inc. In total, 5 filings cover trades dated from 16 August 2022 to 22 December 2025.
Purchases make up the whole of the open-market record (1 purchase, €9,832). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants and 1 option exercise.
On 23 December 2025 came the latest disclosure, a share grant for €8,542 in In8bio, Inc. The last insider purchase was made public on 18 August 2022, 1,528 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations